			Home About us Contact

Artificial Cells (artificial + cell)

Distribution by Scientific Domains

Life Sciences	75%

Selected Abstracts

Capsosomes with Multilayered Subcompartments: Assembly and Loading with Hydrophobic Cargo

ADVANCED FUNCTIONAL MATERIALS, Issue 1 2010
Leticia Hosta-Rigau
Abstract Therapeutic artificial cells or organelles are nanoengineered vehicles that are expected to substitute for missing or lost cellular function. The creation of capsosomes, polymer carrier capsules containing liposomal subcompartments, is a promising approach towards constructing such therapeutic devices using the layer-by-layer assembly method. Herein, the assembly of intact, nonaggregated capsosomes containing multiple liposome layers is reported. It is also further demonstrated that thiocoraline, a hydrophobic model peptide with antitumor activity, can be efficiently loaded into the membrane of the liposomal subcompartments of the capsosomes. Cell viability assays verify the activity of the trapped antitumor cargo. It is also shown that pristine capsosomes do not display inherent cytotoxic effects. The ability to tune the number of liposome layers and hence the drug loading in capsosomes as well as their noncytotoxicity provide new opportunities for the creation of therapeutic artificial cells and organelles. [source]

Building artificial cells and protocell models: Experimental approaches with lipid vesicles

BIOESSAYS, Issue 4 2010
Peter Walde
Abstract Lipid vesicles are often used as compartment structures for preparing cell-like systems and models of protocells, the hypothetical precursor structures of the first cells at the origin of life. Although the various artificially made vesicle systems are already remarkably complex, they are still very different from and much simpler than any known living cell. Nevertheless, the preparation and study of the structure and the dynamics of functionalized vesicle systems may contribute to a better understanding of biological cells, in particular of the essential features of a living cell that are not found in the non-living form of matter. The study of protocell models may possibly lead to a better understanding of the origin of the first cells. To avoid misunderstanding in this field of research, it would be useful if generally accepted definitions of terms like "artificial cells," "synthetic cells," "minimal cells," "protocells," and "primitive cells" exist. , Editor's suggested further reading in BioEssays Synthetic cells and organelles: compartmentalization strategiesAbstract [source]

Synthesis and utilization of E. coli -encapsulated PEG-based microdroplet using a microfluidic chip for biological application

BIOTECHNOLOGY & BIOENGINEERING, Issue 4 2010
Kyoung G. Lee
Abstract We report herein an effective strategy for encapsulating Escherichia coli in polyethylene glycol diacrylate (PEGDA) microdroplets using a microfluidic device and chemical polymerization. PEGDA was employed as a reactant due to the biocompatibility, high porosity, and hydrophilic property. The uniform size and shape of microdroplets are obtained in a single-step process using microfluidic device. The size of microdroplets can be controlled through the changing continuous flow rate. The combination of microdroplet generation and chemical polymerization techniques provide unique environment to produce non-toxic ways of fabricating microorganism-encapsulated hydrogel microbeads. Due to these unique properties of micro-sized hydrogel microbeads, the encapsulated E. coli can maintain viability inside of microbeads and green fluorescent protein (GFP) and red fluorescent protein (RFP) genes are efficiently expressed inside of microbeads after isopropyl- , - D -thiogalactopyranoside induction, suggesting that there is no low-molecular weight substrate transfer limitation inside of microbeads. Furthermore, non-toxic, gentle, and outstanding biocompatibility of microbeads, the encapsulated E. coli can be used in various applications including biotransformation, biosensing, bioremediation, and engineering of artificial cells. Biotechnol. Bioeng. 2010;107:747,751. © 2010 Wiley Periodicals, Inc. [source]